Omixon at East-West Immunogenetics Conference in Prague

28/02/2013

We are glad to announce that Omixon is presenting and exhibiting at East-West Immunogenetics Conference in Prague, Czech Republic, 6-8 March. The main topics are immunogenetics of organ and stem cell transplantation, role of the HLA laboratories in the diagnosis of antibody-mediated rejection, disease association studies and stem cell...

Omixon’s Breakfast Seminar at ASBMT

07/02/2013

Come and join Omixon for a breakfast seminar at to learn about the benefits of using next generation sequencing for transplantation genetics. You will learn how to reduce ambiguity, increase resolution of HLA typing at an affordable price point. The presentation will also address the challenges current early adopters...

Omixon will be attending American Society of Bone and Marrow Transplantation Salt Lake City, 13-17 February 2013

20/01/2013

The American Society for Blood and Marrow Transplantation is an international professional association that promotes the advancement of the blood and marrow transplantation field. ASBMT members are both in clinical practice, in research, and health professionals. From its beginning, ASBMT activities have been representing the interests of transplant clinicians...

Omixon will attend Molecular Medicine TriConference San Francisco, 11-15 Feb 2013

15/01/2013

The Molecular Med Tri-Con is a four day conference which will see more than 3,000 attendees participating in interactive lectures, discussions, and various receptions as a way to facilitate networking opportunities and hearing differing views and perspectives . It includes 2 partnering forums, symposia, short courses, and core programs...

Omixon could be “The Most Promising Company” of 2013

10/01/2013

Omixon is presenting and exhibiting at the upcoming Personalized Medicine World Conference in Mountain View, from 28-29th Jan 2013. We are a nominee for the “The Most Promising Company” award. Emerging companies that develop solutions for the next generation of personalized medicine platforms are invited to the competition.